
Pasirinkite etiketę
rodoma tiesiai ant flakonoSurvodutide
GLP-1
- Siunčiame iš Vokietijos
Užsakymas
- DHL su sekimu
- Diskreti pakuotė
4.6 iš 5 TrustpilotAtsiliepimų: 73
Taip pat ieškoma kaip: Survodutid · BI 456906
Trumpai
Survodutide skaičiais
Pagrindiniai rodikliai iš mūsų žinyno.
Visas žinyno įrašas- Class
- GLP-1 / glucagon dual agonist
- Half-life
- Several daysweekly dose
- Frequency
- Once weeklysubcutaneous
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 10 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to~15 %le Roux et al., Lancet Diabetes & Endocrinology, 2024
Phase 2 study in MASH and liver fibrosis (opens in a new tab)
Sanyal et al., New England Journal of Medicine, 2024Phase 3 trial SYNCHRONIZE-1 in obesity without diabetes (725 adults, 76 weeks) (opens in a new tab)
le Roux et al., New England Journal of Medicine, 2026
Produktui Survodutide laboratorinės analizės dar nėra. Balsuoti už taiUžsakykite tyrimą, mes apmokame pusęVisos laboratorinės analizės
Žinios
Viskas apie Survodutide
Išsami informacija netrukus.
Dozavimas
Įkeliama dozavimo informacija …
Pravers
Ko dar jums reikės
Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.
Insulino švirkštai
10 vnt. · 5.50 €
Spiritinės servetėlės
50 vnt. · 10 €
Kiek vandens?
Vienetai ant švirkšto jūsų flakono dydžiui.
Atidaryti skaičiuoklę →Is Survodutide approved?
No. ChEMBL lists Survodutide with phase 3 as the highest phase. The first phase 3 trials (SYNCHRONIZE-1, SYNCHRONIZE-2 and SYNCHRONIZE-MASLD) are finished and were published in 2026, others are still running. The information here describes the state of research and is not a recommendation for use.
How does Survodutide differ from Semaglutide and Retatrutide?
The receptors. Semaglutide acts only on the GLP-1 receptor, Survodutide also on the glucagon receptor, Retatrutide additionally on GIP. The glucagon part acts mainly in the liver, which is why Survodutide is also tested in fatty liver. In a phase 2 trial in type 2 diabetes the higher levels lowered weight more than semaglutide after 16 weeks.
What did the phase 3 trials show?
In SYNCHRONIZE-1 (without diabetes) weight fell by 12.2 and 13.0 percent after 76 weeks, by 5.4 percent on placebo. In SYNCHRONIZE-2 (with type 2 diabetes) it was 8.2 and 9.8 versus 3.9 percent, HbA1c fell by 0.9 and 0.8 percentage points. In SYNCHRONIZE-MASLD liver fat fell by at least 30 percent in 68.5 percent, on placebo in 28.6 percent.
What is known about the liver?
In a phase 2 trial with biopsy MASH improved without worsening of fibrosis in 43 to 62 percent depending on the dose, in 14 percent on placebo. Fibrosis improved in 34 to 36 versus 22 percent. A study in liver cirrhosis tested uptake and tolerability. Two large phase 3 trials on MASH are still running.
How high were the doses in trials?
The highest study dose was 6 mg per week, in the liver trial and the phase 3 programme. All trials raise the dose in steps over weeks. In the phase 2 trial in overweight the effect rose only a little from the second level on. The entry describes the same principle: start low and only increase until an effect is noticeable. This is not a dosing recommendation.
Which side effects were seen?
Mainly gastrointestinal effects, mostly mild to moderate. In SYNCHRONIZE-1 80.9 and 89.7 percent had them, 47.9 percent on placebo. In the liver trial nausea, diarrhoea and vomiting were clearly more common with Survodutide than with placebo. The trials describe the complaints mainly during escalation.
Which trials are still running?
Three of the listed phase 3 trials are still recruiting: LIVERAGE on MASH with fibrosis (planned end 2031), LIVERAGE-Cirrhosis on MASH with cirrhosis and a trial on blood sugar in type 2 diabetes. The large cardiovascular safety trial with 5,531 participants is finished, results had not been published by October 2026.
Susiję
Susiję produktai
Tirzepatide
Peptidai · GLP-1 ir riebalų mažinimas GLP-1 ir riebalų mažinimas
Dydžių: 10
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Retatrutide
Peptidai · GLP-1 ir riebalų mažinimas GLP-1 ir riebalų mažinimas
Dydžių: 11
Patikrinta laboratorijoje
= nuo 16 €/flakonas
Semaglutide
Peptidai · GLP-1 ir riebalų mažinimas GLP-1 ir riebalų mažinimas
Dydžių: 6
Patikrinta laboratorijoje
= nuo 10 €/flakonas
Mazdutide
Peptidai · GLP-1 ir riebalų mažinimas GLP-1 ir riebalų mažinimas
Dydžių: 2
= nuo 32 €/flakonas
Survodutide